Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Sanofi symbols : Fnctf save search
PRODUCT OF THE YEAR USA NAMES 2024 AWARD WINNERS
Published: 2024-02-09 (Crawled : 14:00) - prnewswire.com
K S | $58.75 1.05% 0.0% 2.3M
|
Consumer Non-Durables
|
| O: -0.38%
H: 0.03%
C: -2.27%
EPC 4 | $38.23 1.38% 0.0% 550K
|
Consumer Non-Durables
|
| O: -0.35%
H: 0.61%
C: 0.31%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.11%
H: 0.0%
C: 0.0%
award year usa
Publicis Groupe : Full Year 2023 Results
Published: 2024-02-08 (Crawled : 07:00) - globenewswire.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: -2.28%
H: 0.0%
C: 0.0%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -1.64%
H: 0.0%
C: 0.0%
K S | $58.75 1.05% 0.0% 2.3M
|
Consumer Non-Durables
|
| O: 3.37%
H: 1.93%
C: -1.01%
KBH A | $64.79 -1.25% -0.93% 800K
|
Consumer Durables
|
| O: 0.25%
H: 1.03%
C: 0.9%
GM | News 4 d | $45.08 -0.04% 0.22% 15M
|
Consumer Durables
|
| O: 0.31%
H: 0.26%
C: -0.49%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -2.25%
H: 0.0%
C: 0.0%
year results
Sanofi Digital Transformation Strategy Analysis Report 2023: Accelerators, Incubators, and Other Innovation Programs
Published: 2024-01-11 (Crawled : 02:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 1.1%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
report innovation sanofi
Incretin-based Drugs Market to Reach $73.9 billion, globally, by 2032 at 7.9% CAGR: Allied Market Research
Published: 2023-12-15 (Crawled : 15:30) - prnewswire.com
AZNCF | News | $140.3 -4.19% 1.5K
|
Health Technology
|
| O: -3.0%
H: 2.15%
C: 2.15%
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVO | News | $126.16 -1.93% -0.23% 3.1M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: -0.44%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -1.31%
H: 0.56%
C: -0.17%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -4.44%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -2.23%
H: 0.28%
C: -0.11%
reach research market
Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
TEVA | $13.01 -0.68% 7.5M
|
Health Technology
|
| O: -0.52%
H: 3.73%
C: 1.87%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -1.09%
H: 0.0%
C: 0.0%
disease treatment collaboration teva deal
Rabies Vaccine Market to Reach $ 1903.17 million by 2032, exhibiting a CAGR of 4.7% from 2023 to 2032: Allied Market Research
Published: 2023-11-25 (Crawled : 08:20) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
| Email alert
Add to watchlist
ELAN | $13.31 -1.11% 0.0% 3.8M
|
Process Industries
| Email alert
Add to watchlist
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $96.0 6.88% 52K
|
Health Technology
| Email alert
Add to watchlist
ZTS | $150.88 0.88% -0.5% 3.6M
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.16 -20.84% 130
|
Communications
| Email alert
Add to watchlist
vaccine reach research market
Teva Reports Third Quarter 2023 Financial Results and Increases Revenue Guidance
Published: 2023-11-08 (Crawled : 14:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
TEVA | $13.01 -0.68% 7.5M
|
Health Technology
|
| O: 2.54%
H: 3.23%
C: -1.29%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
revenue teva financial results
Oral Antibiotics Market to Reach $28.8 Billion, Globally, by 2032 at 2.5% CAGR: Allied Market Research
Published: 2023-10-25 (Crawled : 14:00) - prnewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.4%
H: 1.29%
C: 1.29%
VTRS | News A | $11.55 1.67% 1.65% 7.2M
|
Health Technology
|
| O: -0.44%
H: 0.33%
C: -1.1%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: 0.64%
H: 0.46%
C: -0.09%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.43%
H: 0.64%
C: -0.09%
reach antibiotics research market
Pharmaceutical Suppositories Market to Reach $2.8 Billion, Globally, by 2032 at 5.7% CAGR: Allied Market Research
Published: 2023-10-24 (Crawled : 01:00) - prnewswire.com
VTRS | News A | $11.55 1.67% 1.65% 7.2M
|
Health Technology
|
| O: 0.45%
H: 2.46%
C: 1.67%
NVS | News | $98.35 1.1% 0.0% 2.2M
|
Health Technology
|
| O: -0.17%
H: 1.02%
C: 0.4%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.77%
H: 0.0%
C: 0.0%
reach research market
Antibody Drug Conjugate - Competitive Landscape 2023 Study: Featuring Coverage on 180+ Companies and 300+ Drugs
Published: 2023-06-30 (Crawled : 18:00) - prnewswire.com
SRNE | $0.015 -8.85% 56K
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
| Email alert
Add to watchlist
IMGN | News | $31.23 0.03% 49M
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.16 -20.84% 130
|
Communications
| Email alert
Add to watchlist
drug companies antibody
Antibody-drug Conjugates Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain
Published: 2023-06-26 (Crawled : 21:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: 2.15%
H: 1.18%
C: 0.43%
SRNE | $0.015 -8.85% 56K
|
Health Technology
|
| O: -1.0%
H: 4.2%
C: 1.3%
SGEN | $228.74 0.1% 20M
|
Health Technology
|
| O: 0.82%
H: 0.02%
C: -0.85%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.17%
H: 0.0%
C: 0.0%
OMER | $3.04 -1.62% -1.64% 250K
|
Health Technology
|
| O: 0.19%
H: 2.22%
C: 1.76%
IMGN | News | $31.23 0.03% 49M
|
Health Technology
|
| O: 0.58%
H: 2.57%
C: 0.26%
companies pipeline trial
Extended Release Injectable Drugs Research Report 2023: Formulation Technologies & Platforms, Physical Process Control Methods, Development Factors, Competitive Landscape
Published: 2023-06-16 (Crawled : 23:00) - prnewswire.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
| Email alert
Add to watchlist
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
| Email alert
Add to watchlist
report control research
IPG Named Most Effective Holding Company at the U.S. Effie Awards
Published: 2023-06-02 (Crawled : 22:00) - interpublic.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.16 -20.84% 130
|
Communications
| Email alert
Add to watchlist
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
| Email alert
Add to watchlist
awards
IPG Receives Back-to-Back Title as Most Effective Holding Company at the Effie Awards
Published: 2023-06-02 (Crawled : 20:00) - interpublic.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
| Email alert
Add to watchlist
FNCTF | News | $11.16 -20.84% 130
|
Communications
| Email alert
Add to watchlist
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
| Email alert
Add to watchlist
awards
Nutriband Inc. to Present at the 2023 Transdermal and Microneedle Conference
Published: 2023-01-24 (Crawled : 11:00) - nutriband.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.27%
H: 0.1%
C: 0.1%
NTRB | $3.56 -8.76% 3.4K
|
Manufacturing
|
| O: -2.85%
H: 0.0%
C: -1.76%
RANI | $6.87 2.69% 2.62% 140K
|
|
| O: -1.1%
H: 1.91%
C: -3.82%
MRK | $127.0 0.1% -1.21% 7.1M
|
Health Technology
|
| O: 0.11%
H: 0.0%
C: -1.35%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: -0.86%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.72%
H: 0.0%
C: 0.0%
conference transdermal
Pfizer and BioNTech Receive U.S. FDA Fast Track Designation for Single-Dose mRNA-Based Vaccine Candidate Against COVID-19 and Influenza
Published: 2022-12-09 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.06%
H: 2.11%
C: -0.06%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.15%
H: 0.0%
C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -0.05%
H: 0.75%
C: -0.83%
covid-19 fda designation candidate vaccine influenza fast track designation
Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization for Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine in Children Under 5 Years
Published: 2022-12-08 (Crawled : 16:00) - globenewswire.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: -0.76%
H: 0.0%
C: 0.0%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 0.5%
H: 0.16%
C: 0.16%
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.12%
H: 3.36%
C: 3.19%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -1.32%
H: 0.0%
C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 0.37%
H: 5.31%
C: 5.26%
covid-19 fda children vaccine authorization
Pfizer and BioNTech Report New Data on Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Improved Immune Response Against Emerging Omicron Sublineages
Published: 2022-11-18 (Crawled : 12:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 1.56%
H: 0.52%
C: 0.52%
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 0.64%
H: 0.39%
C: -0.84%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 2.2%
H: 0.0%
C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -0.29%
H: 0.78%
C: 0.37%
report response
Pfizer and BioNTech Advance Next-Generation COVID-19 Vaccine Strategy with Study Start of Candidate Aimed at Enhancing Breadth of T cell Responses and Duration of Protection
Published: 2022-11-16 (Crawled : 00:00) - globenewswire.com
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -1.22%
H: 0.0%
C: 0.0%
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.52%
H: 1.45%
C: 1.11%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -2.28%
H: 0.0%
C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -1.45%
H: 2.36%
C: 2.31%
covid-19 candidate vaccine study
Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine
Published: 2022-11-04 (Crawled : 11:00) - globenewswire.com
FNCTF | News | $11.16 -20.84% 130
|
Communications
|
| O: 4.93%
H: 0.0%
C: 0.0%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.02%
H: 0.43%
C: 0.43%
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: 1.93%
H: 0.15%
C: -0.53%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 2.05%
H: 0.0%
C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 7.6%
H: 0.33%
C: -1.27%
covid-19 vaccine response
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.